4 Amendments of Gianni PITTELLA related to 2012/0366(COD)
Amendment 322 #
Proposal for a directive
Article 2 – paragraph 1 – point 23 – point i (new)
Article 2 – paragraph 1 – point 23 – point i (new)
(i) ‘reduced-risk tobacco product’ means a novel tobacco product with a limited effect on health as attested by scientific evidence;
Amendment 1116 #
Proposal for a directive
Article 17 – title
Article 17 – title
Notification of novel tobacco products including reduced-risk tobacco products
Amendment 1125 #
Proposal for a directive
Article 17 – paragraph 1 – introductory part
Article 17 – paragraph 1 – introductory part
1. Member States shall require that manufacturers and importers of tobacco products notify the competent authorities of Member States of any novel tobacco product, including reduced-risk products, they intend to place on the markets of the Member States concerned. The notification shall be submitted in electronic form six months before the intended placing on the market and shall be accompanied by a detailed description of the product in question as well as information on ingredients and emissions in accordance with Article 5. The manufacturers and importers notifying a novel tobacco product, including reduced-risk products, shall also provide the competent authorities in question with:
Amendment 1135 #
Proposal for a directive
Article 17 – paragraph 2
Article 17 – paragraph 2
2. Member States shall require that manufacturers and importers of tobacco products inform their competent authorities of any new or updated information referred to in point (a) to (c) of paragraph 1. Member States shall be entitled to require tobacco manufacturers or importers to carry out additional tests or submit additional information. Member States shall make available to the Commission all information received pursuant to this Article. Member States shall be entitled to introduce an authorisation system and charge a proportionate fee. Before granting authorisation to place a novel product, including reduced-risk products, on the market, Member States shall establish and render mandatory: the standards applicable to their marketing and the types of information provided to the public, focusing on the characteristics apt to markedly reducing the risk of contracting one or more tobacco-related diseases.